The US Food and Drugs Administration has approved the use of remdesivir for treating coronavirus patients. The are clear to state that is not a cure nor a vaccine and that it does not affect the mortality rate. what it does do is cut the time for those in a serious condition but who are expected to recover by about a third. This takes pressure off the health care system. It is only approved for the States and supplies are restricted but the outcome is worth keeping an eye on.
The UK, along with a number of other countries, is now collecting blood plasma from people who had Covid-19 and recovered, providing they test positive for anti-bodies in sufficient numbers. The plasma will then be transfused into patients with a severe form of the disease to help their immune systems build up better resistance to aid recovery. The treatment has been around for a long time with varied results but it did prove to be a success with Ebola so well worth the effort.
The next bit of good news is that if you have had the virus and recovered you will not catch it again. That fits with a lot of viruses. There were reports that some people who had the virus were falling ill with it again but scientists and doctors in South Korea looked at the results again and found that faulty tests were responsible and not a new form of the disease.